Section Arrow
GH.NASDAQ
- Guardant Health
Quotes are at least 15-min delayed:2026/09/02 06:43 EDT
Pre Market
Last
 --
-- (--)
Bid
145
Ask
178
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 164.41
+5.39 (+3.39%)
Day High 
165.63 
Prev. Close
159.02 
1-M High
173.1699 
Volume 
2.44M 
Bid
145
Ask
178
Day Low
156.32 
Open
158.5 
1-M Low
155 
Market Cap 
21.34B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 165.01 
20-SMA 163.75 
50-SMA 157.31 
52-W High 176.58 
52-W Low 53.4 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.51/-0.29
Enterprise Value
23.02B
Balance Sheet
Book Value Per Share
-1.66
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
982.02M
Operating Revenue Per Share
3.99
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies Inc6.59+2.03+44.52%-- 
Pre Market 6.4 -0.19 -2.88%
PSNLPersonalis17.06+0.28+1.67%-- 
Pre Market 16.95 -0.11 -0.64%
DHRDanaher Corp206.93-6.63-3.10%38.07PE
Pre Market 208.22 +1.29 +0.62%
RVTYRevvity126.59-2.08-1.62%61.86PE
Pre Market -- -- --
OPKOPKO Health1.52+0.05+3.40%-- 
Pre Market 1.53 +0.01 +0.66%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.